- 询价
- PEPROTECH
- ZK-0098175
- 中国/美国
- 2025年11月20日
2 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
1000
- 英文名：
Recombinant Collagen Type VI (COL6)
- 保质期：
12个月
- 供应商：
上海再康
- 保存条件：
-20℃
VI型胶原(COL6)重组蛋白
Recombinant Collagen Type VI (COL6)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
| Organism species | Homo sapiens (Human) |
| Product No. | RPD123Hu01 |
| Source | Prokaryotic expression |
| Host | E.coli |
| Purity | > 90% |
| UOM | 50ug |
| Predicted Molecular Mass | 42.8kDa |
| Concentration | n/a |
| Applications | SDS-PAGE; WB; ELISA; IP. |
| Endotoxin Level | <1.0EU per 1µg (determined by the LAL method) |
| Residues | Met1~Asp336 with two N-terminal Tags, His-tag and T7-tag |
| Formulation | Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative. |
VI型胶原(COL6)重组蛋白 SEQUENCES
The sequence of the target protein is listed below.
MKKEHVLHCQ FSAWYPFFRG VTIKSVILPL PQNVKDYLLD DGTLVVSGRD DPPTHSQPDS DDEAEEIQWS DDENTATLTA PEFPEFATKV QEAINSLGGS VFPKLNWSAP RDAYWIAMNS SLKCKTLSDI FLLFKSSDFI TRDFTQPFIH CTDDSPDPCI EYELVLRKWC ELIPGAEFRC FVKENKLIGI SQRDYTQYYD HISKQKEEIR RCIQDFFKKH IQYKFLDEDF VFDIYRDSRG KVWLIDFNPF GEVTDSLLFT WEELISENNL NGDFSEVDAQ EQDSPAFRCT NSEVTVQPSP YLSYRLPKDF VDLSTGEDAH KLIDFLKLKR NQQEDD
MKKEHVLHCQ FSAWYPFFRG VTIKSVILPL PQNVKDYLLD DGTLVVSGRD DPPTHSQPDS DDEAEEIQWS DDENTATLTA PEFPEFATKV QEAINSLGGS VFPKLNWSAP RDAYWIAMNS SLKCKTLSDI FLLFKSSDFI TRDFTQPFIH CTDDSPDPCI EYELVLRKWC ELIPGAEFRC FVKENKLIGI SQRDYTQYYD HISKQKEEIR RCIQDFFKKH IQYKFLDEDF VFDIYRDSRG KVWLIDFNPF GEVTDSLLFT WEELISENNL NGDFSEVDAQ EQDSPAFRCT NSEVTVQPSP YLSYRLPKDF VDLSTGEDAH KLIDFLKLKR NQQEDD
VI型胶原(COL6)重组蛋白 USAGE
Reconstitute in sterile ddH2O.
STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
VI型胶原(COL6)重组蛋白 About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
vi. 利用激光动态光散射仪检测蛋白是否复性。
多糖和蛋白质的结合疫苗 由多糖抗原 与蛋白质偶联而成。多糖对人体无毒性、容易产生、结构稳定，广泛存在这细菌表面抗原结构中。该种疫苗具有能诱导婴幼儿产生保护性免疫应答的优点。因此在设计上首先选择能够产生较好保护性免疫反应的多糖抗原，载体蛋白应安全、可靠，通过还原胺化、酰胺缩合、硫醚缩合等方法进行多糖和载体蛋白的偶联。 目前，在细菌性结合疫苗中所使用的载体蛋白有：白喉毒素、霍乱毒素、重组蛋白D、膜蛋白质、外膜蛋白质、链球菌C外膜蛋白质以及与多糖抗原同源的细菌外源蛋白等。多糖成分有：脱
腺病毒载体的优点： 1. 宿主范围广, 对人致病性低 腺病毒载体系统可广泛用于人类及非人类蛋白的表达。腺病毒可感染一系列哺乳动物细胞，因此在大多哺乳动物细胞和组织中均可用来表达重组蛋白。特别需要指出的是：腺病毒具有嗜上皮细胞性，而人类的大多数的肿瘤就是上皮细胞来源的。另外，腺病毒的复制基因和致病基因均已相当清楚，在人群中早已流行（70-80%成人体内都有腺病毒的中和抗体存在）。人类感染野生型腺病毒后仅产生轻微的自限性症状，且病毒唑治疗有效。 2. 在增殖和非增殖细胞中感染
技术资料暂无技术资料 索取技术资料
VI型胶原(COL6)重组蛋白
询价
